Technical Analysis for ACET - Adicet Bio, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.40 | 5.26% | 0.07 |
ACET closed up 5.26 percent on Wednesday, May 15, 2024, on 1.88 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: Jun 5
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Wide Bands | Range Expansion | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Wide Bands | Range Expansion | 5.26% | |
| Gapped Up | Strength | 5.26% | |
| Down 3 Days in a Row | Weakness | 5.26% | |
| Down 4 Days in a Row | Weakness | 5.26% | |
| Down 5 Days in a Row | Weakness | 5.26% | |
| Oversold Stochastic | Weakness | 5.26% | |
| Stochastic Reached Oversold | Weakness | -2.78% |
| Alert | Time |
|---|---|
| 1.5x Volume Pace | about 14 hours ago |
| Gap Up Partially Closed | about 14 hours ago |
| Rose Above Previous Day's High | about 14 hours ago |
| 10 DMA Resistance | about 14 hours ago |
| Up 1 ATR | about 14 hours ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 06/05/2024
Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell T Cell Therapies For Cancer Chimeric Antigen Receptor Adoptive Cell Transfer Antigen Immune Response
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell T Cell Therapies For Cancer Chimeric Antigen Receptor Adoptive Cell Transfer Antigen Immune Response
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 6.71 |
| 52 Week Low | 1.1 |
| Average Volume | 1,414,140 |
| 200-Day Moving Average | 1.93 |
| 50-Day Moving Average | 2.01 |
| 20-Day Moving Average | 1.66 |
| 10-Day Moving Average | 1.52 |
| Average True Range | 0.17 |
| RSI (14) | 35.06 |
| ADX | 19.52 |
| +DI | 16.46 |
| -DI | 29.56 |
| Chandelier Exit (Long, 3 ATRs) | 1.83 |
| Chandelier Exit (Short, 3 ATRs) | 1.85 |
| Upper Bollinger Bands | 2.11 |
| Lower Bollinger Band | 1.21 |
| Percent B (%b) | 0.21 |
| BandWidth | 54.44 |
| MACD Line | -0.18 |
| MACD Signal Line | -0.17 |
| MACD Histogram | -0.0098 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.63 | ||||
| Resistance 3 (R3) | 1.64 | 1.59 | 1.59 | ||
| Resistance 2 (R2) | 1.59 | 1.53 | 1.58 | 1.57 | |
| Resistance 1 (R1) | 1.49 | 1.49 | 1.47 | 1.48 | 1.56 |
| Pivot Point | 1.44 | 1.44 | 1.42 | 1.43 | 1.44 |
| Support 1 (S1) | 1.34 | 1.38 | 1.32 | 1.33 | 1.24 |
| Support 2 (S2) | 1.29 | 1.34 | 1.28 | 1.23 | |
| Support 3 (S3) | 1.19 | 1.29 | 1.21 | ||
| Support 4 (S4) | 1.18 |
